161 related articles for article (PubMed ID: 22818843)
1. Diaphragmatic rupture, a new complication of Bevacizumab.
Lacaze L; Scotté M
Eur J Surg Oncol; 2012 Nov; 38(11):1079-81. PubMed ID: 22818843
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.
Ganapathi AM; Westmoreland T; Tyler D; Mantyh CR
J Am Coll Surg; 2012 Apr; 214(4):582-8; discussion 588-90. PubMed ID: 22321523
[TBL] [Abstract][Full Text] [Related]
3. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
August DA; Serrano D; Poplin E
J Surg Oncol; 2008 Feb; 97(2):180-5. PubMed ID: 18095268
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic management of colonic perforation owing to angiogenesis inhibitors.
Ezzedine S; Bege T; Berdah S; Vitton V; Grimaud JC; Barthet M
Surg Laparosc Endosc Percutan Tech; 2010 Dec; 20(6):e230-2. PubMed ID: 21150409
[TBL] [Abstract][Full Text] [Related]
5. [Surgical management of bevacizumab-associated peritonitis due to perforation].
Kube R; Meyer F; Bien N; Schmidt C; Mroczkowski P; Dalicho S; Lippert H
Zentralbl Chir; 2009 Sep; 134(5):462-7. PubMed ID: 19757347
[TBL] [Abstract][Full Text] [Related]
6. Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.
Hompes D; Ruers T
Eur J Surg Oncol; 2011 Sep; 37(9):737-46. PubMed ID: 21764243
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab-induced bowel perforation.
Sliesoraitis S; Tawfik B
J Am Osteopath Assoc; 2011 Jul; 111(7):437-41. PubMed ID: 21803880
[TBL] [Abstract][Full Text] [Related]
8. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
de Melo JV; Vieira de Melo MS; Abad MH
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.
Thornton AD; Ravn P; Winslet M; Chester K
Br J Surg; 2006 Dec; 93(12):1456-63. PubMed ID: 17115389
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
Shih T; Lindley C
Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
[TBL] [Abstract][Full Text] [Related]
11. Trials of bevacizumab in breast cancer--a safety review.
Kümler I; Nielsen DL
Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S37-48. PubMed ID: 21663533
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy.
Burkart CM; Grisel JJ; Hom DB
Laryngoscope; 2008 Sep; 118(9):1539-41. PubMed ID: 18622319
[TBL] [Abstract][Full Text] [Related]
13. [A case of delayed colonic perforation after metallic stent placement for advanced descending colon cancer during bevacizumab-based chemotherapy].
Tanaka I; Hisai H; Miyazaki E; Ono M; Maeda Y; Sato M; Kawasaki R; Gyobu H; Nakajima S; Yamada S; Muramatsu H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2319-21. PubMed ID: 22202368
[TBL] [Abstract][Full Text] [Related]
14. Delayed bile leak with avastin after liver resection for metastatic colorectal cancer.
Lordan JT; Wilkins M; Karanjia ND
Hepatogastroenterology; 2011; 58(110-111):1769-70. PubMed ID: 22086700
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab in lung cancer: lackluster performance and unjustified expense?
Dasanu CA
J Oncol Pharm Pract; 2012 Sep; 18(3):381-2. PubMed ID: 22777997
[TBL] [Abstract][Full Text] [Related]
16. Refractory generalized seizures as a possible side effect of bevacizumab in a colon cancer patient.
Berk V; Ismailogullari S; Donmez H; Karaca H; Inanc M; Ozkan M
Med Oncol; 2012 Jun; 29(2):1017-9. PubMed ID: 21461780
[TBL] [Abstract][Full Text] [Related]
17. Acute and severe acne in a patient treated with bevacizumab.
Molina-Ruiz AM; Domine M; Requena L
Int J Dermatol; 2013 Apr; 52(4):486-90. PubMed ID: 23432695
[TBL] [Abstract][Full Text] [Related]
18. GI perforation associated with bevacizumab.
Yoon SS; Rivera R; Shah A; Ozden N
Gastrointest Endosc; 2012 Jun; 75(6):1286-7. PubMed ID: 21862004
[No Abstract] [Full Text] [Related]
19. Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer.
Stevenson JP; Langer CJ; Somer RA; Evans TL; Rajagopalan K; Krieger K; Jacobs-Small M; Dyanick N; Milcarek B; Coakley S; Walker S; Eaby-Sandy B; Hageboutros A
Cancer; 2012 Nov; 118(22):5580-7. PubMed ID: 22544579
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab: overview of the literature.
Braghiroli MI; Sabbaga J; Hoff PM
Expert Rev Anticancer Ther; 2012 May; 12(5):567-80. PubMed ID: 22594892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]